Vinod Dhakad, Abhijit Deshmukh


Aim of this study is to analyse the clinical profile of locally advanced oral carcinoma and to compare the prognosis of patients who underwent neoadjuvant chemotherapy followed by surgery to that of those who underwent primary surgery.

Material and Methods: It was a Prospective, Randomized study done in the Department of Surgery and Oncology, Chirayu Medical college and hospital Bhopal from November 2012 to November 2017.Patients Population studied was 50 (25 in each arm).

Results: Most common age group was 40-49 years, with median age of 44 years in both the arms. Ulcer and trismus were the most common symptoms in both the arms, about 95% and 60% respectively, with median duration of 3 months. Most common lesions were ulcero-proliferative (61%) arising from gingivi- buccal complex and ulcero- infiltrative (39%) with median diameter of 4 cm and skin involvement of 5cm. In this study following neo-adjuvant chemotherapy 19 out of 25 patients(76%) had partial response, 2 patients (8%) had complete response to NACT, 3 patients(12 %) had stable disease and 1 patient (4%) had progression of disease despite two/three cycles of NACT.

Conclusion: It has been suggested that in the advent of newer chemotherapy molecules and regimens and more aggressive drug combinations might result in survival benefit after NACT schedule. This study convincingly demonstrated the feasibility of induction chemotherapy with acceptable results.


Oral carcinoma, Neoadjuvant chemotherapy, Ulcero-proliferative, Induction chemotherapy, Head carcinoma, Neck carcinoma.


Chaudhary AJ, Pande SC, Sharma V, Bhalavat RL, Shrivastava SK, Gonsalves MA, Hingorani CB, and Dinshaw KA. (1989). “Radiotherapy of Carcinoma of the the buccal mucosa”, Semin Surg. Onco, Vol.5(5), pp.322-326.

Depondt J, et al. (1993). “Neoadjuvant chemotherapy with carboplatin, 5 FU in head and neck”, cancer oncology, Vol.50, pp.23-27.

Dhawan IK, Verma K, Khazanchi RK, Madan NC, Shukla NK, and Saxena R. (1993). Carcinoma of buccal mucosa: incidence of regional lymph node involvement”, Indian Journal of Cancer, Vol.30, pp.176-180.

Diaz EM Jr, Holsinger FC, Zuniga ER, Roberts DB, and Sorensen DM. (2003). “Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients”, Head Neck, Vol.25, pp.267-273.

DiBasio B, Barbieri W, and Bozettu A, et al. (1994). “A prospective randomized trial in resectable head and neck carcinoma: Locoregional treatment with and without neoadjuvant chemotherapy”, ASCO, Vol.13, p.279.

Domenge C, et al. (1996). “Randomized controlled trial of neoadjuvant chemotherapy before radiotherapy in oropharyngeal carcinoma”, Proceedings of 4th international conference on Head and neck cancer, Toronto, p.99.

Fang FM, Leung SW, Huang CC, Liu YT, Wang CJ, Chen HC, Sun LM, and Huang DT. (1997). “Combined modality therapy for squamous carcinoma of the buccal mucosa: Treatment results and prognostic factors”, Head and Neck, Vol.19, pp.506-512.

Jabar MA, Porter SR, and Gilthorpe MS, et al. (1999). “Risk factors for oral epithelial dysplasia. The role of smoking and alcohol”, oral oncol, Vol.35, pp.151-156.

Jaulerry C, et al. (1992). “Induction chemotherapy in advanced head and neck tumors, Results of two randomized trials”, Int. J. Radit. Oncol. Bilo Phys, Vol.23, pp.483-489.

Juan J Grau et al. (2002). “ASCO Annual meeting: Neoadjuvant CTas organ preservation strategy in cancer of oral cavity”.

Khalifa A, and Al khobouri M. (2004). “Treatment results of NAC in advance Head and Neck cancer in Oman”, Journal of the Egyptian Nat. Cancer Inst, June, Vol.16(2), pp.99-106.

Kohno N, Ichikawa G, Nakazawa E, et al. (1995). “Induction CT with Cisplatin Etoposide and mitomycin-C regimen in advanced cases with Cancer of Pharynx and cord cavity”, Aurisnasur Larynx, Vol.22, pp.49-52.

Lee KH, et al. (2005). “Role of combined modality treatment of BM-SCC”, Australian Dental Journal, Vol.50(2), pp.108-113.

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R, and Cantù G. (2003). “Primary Chemotherapy in resectable squamous cell cancer: A randomized controlled trial”, J Clin Oncol, Vol.21(2), pp.327-333.

Martin M, et al. (1990). “Randomized study of % flurouracil and cisplatin as neoadjuvant therapy in head and neck cancer. A preliminary report”, Int. J. Radiat Onco Biol. Phys, Vol.19, pp.973-975.

Mazeron JJ, Martin M, and Brun B, et al. (1992). “Induction CT in Head and Neck cancer results of a phase III trial”, head and Neck, Vol.14, pp.85-91.

Paccagnella A, et al. (1994). “Phase III Trial of initial chemotherapy in stage III or IV Head and Neck cancers”, J Natl. Cancer Inst, Vol.86, pp.265-272.

Pathak KA, Gupta S, Talole S, and Khanna V, et al. (2005). “Advanced squamous cell carcinoma of lower gingivobuccal complex: Patterns of spread and failure”, Head Neck, Vol.27(7), pp.597-602.

Richard JM, et al. (1991). “Randomized EORTC Head and Neck of group trial preoperative intra-arterial chemotherapy in oral cavity & Oropharynx carcinoma”, Eur J of cancer, Vol.27, pp.821-827.

Schuller DE, Stern DW, Metch B, Mattox D, and Mccracken JD. (1988). “Preoperative Chemotherapy in Advanced resectable Head and Neck cancer: Final report of the southwest oncology group”, Laryngoscope, Vol.98, pp.1205-1211.

Urist MM, O’Brien CJ, Soong SJ, Visscher DW, and Maddox WA. (1987). “Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors”, Am. J Surg, Vol.154(4), pp.411-441.


  • There are currently no refbacks.

Send mail to ijsss@ijsss.com with questions or comments about this web site. 

International Journal of Surgery and Surgical Sciences, All rights reserved.